93 related articles for article (PubMed ID: 7487228)
1. Immune response of mice infected with Schistosoma mansoni is modulated by antifibrotic treatment.
Giboda M; Jacobs P; Smith JM; Miller SC
Ann Trop Med Parasitol; 1995 Aug; 89(4):415-24. PubMed ID: 7487228
[TBL] [Abstract][Full Text] [Related]
2. Treatment of acute schistosomiasis mansoni with praziquantel and an antifibrotic agent in mice. Maintenance of resistance to infection.
Hassan SI; Ali I; Nessim NG; Amer NM; Abd el Kader el Khafif M; Ashour A; el Mohandes M
Arzneimittelforschung; 2003; 53(6):440-4. PubMed ID: 12872615
[TBL] [Abstract][Full Text] [Related]
3. Reduction in tissue egg load and maintenance of resistance to challenge in mice infected with Schistosoma mansoni, following combined treatment with praziquantel and an antifibrotic agent.
Giboda M; Smith JM; Prichard RK
Ann Trop Med Parasitol; 1994 Aug; 88(4):385-95. PubMed ID: 7979626
[TBL] [Abstract][Full Text] [Related]
4. Experimental schistosomiasis mansoni: modulation of granulomas by inhibition of collagen cross-link formation. Preliminary report.
Giboda M; Zenka J; Julis I; Vítovec J
Ann Trop Med Parasitol; 1992 Dec; 86(6):631-6. PubMed ID: 1304705
[TBL] [Abstract][Full Text] [Related]
5. Impact of antifibrotic treatment of the course of Schistosoma mansoni infection in murine model.
Giboda M; Smith JM
Mem Inst Oswaldo Cruz; 1997; 92(5):693-7. PubMed ID: 9566241
[TBL] [Abstract][Full Text] [Related]
6. Potential antifibrotic effects of AT1 receptor antagonist, losartan, and/or praziquantel on acute and chronic experimental liver fibrosis induced by Schistosoma mansoni.
El-Lakkany NM; El-Maadawy W; Ain-Shoka A; Badawy A; Hammam O; Ebeid F
Clin Exp Pharmacol Physiol; 2011 Oct; 38(10):695-704. PubMed ID: 21762203
[TBL] [Abstract][Full Text] [Related]
7. Effect of combined praziquantel and recombinant glutathione S-transferase on resistance to reinfection in murine Schistosomiasis mansoni.
Botros SS; Makary EA; Ahmed KM; Ibrahim AM; Nashed NN; El-Nahal HM; Doughty BL; Hassanein HI
Int J Immunopharmacol; 2000 Nov; 22(11):979-88. PubMed ID: 11090706
[TBL] [Abstract][Full Text] [Related]
8. Effect of a combination of the new antischistosomal drug Ro 15-5458 and praziquantel on different strains of Schistosoma mansoni infected mice.
Kamel G; Metwally A; Guirguis F; Nessim NG; Noseir M
Arzneimittelforschung; 2000 Apr; 50(4):391-4. PubMed ID: 10800639
[TBL] [Abstract][Full Text] [Related]
9. Adult worm tegumental damage and egg-granulomas in praziquantel-resistant and -susceptible Schistosoma mansoni treated in vivo.
Liang YS; Coles GC; Dai JR; Zhu YC; Doenhoff MJ
J Helminthol; 2002 Dec; 76(4):327-33. PubMed ID: 12498638
[TBL] [Abstract][Full Text] [Related]
10. The hepatoprotective activity of blue green algae in Schistosoma mansoni infected mice.
Mohamed AH; Osman GY; Salem TA; Elmalawany AM
Exp Parasitol; 2014 Oct; 145():7-13. PubMed ID: 25016189
[TBL] [Abstract][Full Text] [Related]
11. Effect of adamantylamide dipeptide on reinfection resistance after primary infection eradication in experimental Schistosomiasis mansoni.
Botros S; Mahmoud S; Hassan S; Ibrahim A; Zidek Z; Masek K
Arzneimittelforschung; 1996 Jan; 46(1):74-8. PubMed ID: 8821522
[TBL] [Abstract][Full Text] [Related]
12. Immunohistopathological and biochemical changes in Schistosoma mansoni-infected mice treated with artemether.
Botros SS; Mahmoud MR; Moussa MM; Nosseir MM
J Infect; 2007 Nov; 55(5):470-7. PubMed ID: 17868901
[TBL] [Abstract][Full Text] [Related]
13. Parasitological, hematological and ultrastructural study of the effect of COX-2 inhibitor, pyocyanin pigment and praziquantel, on S. mansoni infected mice.
Mohamed AH; Ezz El-Din N; Fahmy ZH; El-Shennawy AM; Hassan E
J Egypt Soc Parasitol; 2006 Apr; 36(1):197-220. PubMed ID: 16605111
[TBL] [Abstract][Full Text] [Related]
14. Effect of adamantylamide dipeptide as adjuvant therapy to praziquantel in mice infected with different S. mansoni isolates.
Botros S; Mahmoud M; Hammam O; Salah F; Zidek Z; Masek K
APMIS; 2006; 114(7-8):480-91. PubMed ID: 16907853
[TBL] [Abstract][Full Text] [Related]
15. Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel.
Ismail M; Metwally A; Farghaly A; Bruce J; Tao LF; Bennett JL
Am J Trop Med Hyg; 1996 Aug; 55(2):214-8. PubMed ID: 8780463
[TBL] [Abstract][Full Text] [Related]
16. Correlation between infection intensity, serum immunoglobulin profile, cellular immunity and the efficacy of treatment with praziquantel in murine schistosomiasis mansoni.
Nessim NG; Demerdash Z
Arzneimittelforschung; 2000 Feb; 50(2):173-7. PubMed ID: 10719623
[TBL] [Abstract][Full Text] [Related]
17. Parasitological and histo-pathological studies on schistosomiasis mansoni infected mice and treated with praziquatel and/or oltipraz.
Morsy GH
J Egypt Soc Parasitol; 2009 Aug; 39(2):687-701. PubMed ID: 19795775
[TBL] [Abstract][Full Text] [Related]
18. Possible antifibrotic effect of GDC-0449 (Vismodegib), a hedgehog-pathway inhibitor, in mice model of Schistosoma-induced liver fibrosis.
Elhenawy AA; Ashour RH; Nabih N; Shalaby NM; Megahed N
Parasitol Int; 2017 Oct; 66(5):545-554. PubMed ID: 28408356
[TBL] [Abstract][Full Text] [Related]
19. Doxycycline aggravates granulomatous inflammation and lung microstructural remodeling induced by Schistosoma mansoni infection.
Santos MP; Gonçalves-Santos E; Gonçalves RV; Santos EC; Campos CC; Bastos DSS; Marques MJ; Souza RLM; Novaes RD
Int Immunopharmacol; 2021 May; 94():107462. PubMed ID: 33611055
[TBL] [Abstract][Full Text] [Related]
20. Levamisole restored the compromised state of immunity after specific chemotherapy in experimental schistosomiasis mansoni.
Botros SS; Hassan SI; el-Nahal HM; Azab ME; Shaker ZA; el-Garem A
Immunopharmacol Immunotoxicol; 1989; 11(4):611-29. PubMed ID: 2516861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
